› Forums › General Melanoma Community › Question for Tim regarding FDA approval of GSK drugs
- This topic has 3 replies, 1 voice, and was last updated 10 years, 6 months ago by Golda_.
- Post
-
- June 11, 2013 at 1:19 pm
Hi Tim,
Hi Tim,
Do you know whether those who are BRAF 600E positive and have had Zelboraf in the past are eligible for the GSK BRAF and/or MEK inhibitor? I read the GSK press release which states that the BRAF inhibitor (Tafinlar) is not indicated for use for those who have BRAF-wildtype melanoma. For the MEK inhibitor (Mekinist), it says the same thing and also that it is "not indicated for the treatment of patients who have received a prior BRAF therapy." If that's the case, it seems that everyone who has had Zelboraf cannot have the MEK inhibitor.
Could you please clarify this issue?
Thanks so much.
Viewing 2 reply threads
- Replies
Viewing 2 reply threads
- You must be logged in to reply to this topic.